Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Digital Health

Therapeutic area intelligence for Digital Health with 8 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals
8
Catalysts
0
Companies
3

Companies

ACDP-O →
digital health therapeutics →
digital therapeutics companies →

Assets

Adhera →
Digital →
Web-Based →

Recent signals(8)

ClinicalAugust 8, 2026

Study on Digital Health Interventions for Cardiovascular Disease Prevention Post-HDP

The study focuses on mobile health interventions aimed at preventing cardiovascular disease in individuals with a history of hypertensive disorders of pregnancy.

Clinical
August 7, 2026

Digital Lifestyle Intervention Trial Aims to Improve Cardiovascular Health Outcomes

A multi-center randomized controlled trial is evaluating a digital lifestyle intervention's impact on cardiovascular health in Swedish primary healthcare.

ClinicalAugust 6, 2026

Study on KIOS App for Opioid Use Disorder Effectiveness and Implementation

The KIOS app is being evaluated for its real-world effectiveness in aiding recovery from opioid addiction.

ClinicalAugust 3, 2026

Study on Digital Health Solutions for Type 2 Diabetes Patients Initiated

A prospective study will assess the effectiveness of digital health solutions in managing Type 2 Diabetes over 12 weeks.

CompetitiveJuly 29, 2026

Adhera Health's ACDP-O Study Targets Obesity in Youth with Chronic Conditions

Adhera Health is conducting a feasibility study on its family-centered digital health intervention for obesity in adolescents and young adults with chronic conditions.

ClinicalJuly 23, 2026

Study on Smartphone-Based Heart Sound Analysis Using AI

The University of Hong Kong is conducting an observational study to evaluate the ausculto™ software for analyzing heart sounds via smartphones.

ClinicalJuly 10, 2026

Digital Health Intervention for Young Adult Cancer Survivors Under Study

A study is underway to evaluate a digital health intervention aimed at improving well-being in young adult cancer survivors.

ClinicalJune 22, 2026

Web-Based Nurse Support Program Improves Cancer Screening Knowledge and Attitudes

A randomized controlled trial demonstrated that a web-based interactive nurse support program significantly improved knowledge, attitudes, and behaviors regarding cancer screening among participants aged 30 to 70.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Cardiovascular Disease →
Diabetes →
Obesity →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.